|
|
|
Financials-Kopran Limited| Sector: Bulk Drugs and Formulations | | BSE:524280 | NSE:KOPRAN | Bloomberg:KOP@IN | Reuters:KPRN.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE082A01010 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2020(3) |
% Change |
| Sales of Products/Services |
619.65 |
385.87 |
60.59 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
22.34 |
5.20 |
329.62 |
| Total Income |
641.99 |
391.07 |
64.16 |
| Total Expenses |
-564.91 |
-365.21 |
54.68 |
| OPBDIT |
1206.90 |
756.28 |
59.58 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-10.46 |
-365.21 |
-97.14 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-20.69 |
-7.88 |
162.56 |
| After Tax Profit |
56.39 |
17.98 |
213.63 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-06(12) |
|
31-Mar-05(12) |
|
31-Mar-04(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
1283.22 |
90.14 |
1017.14 |
98.87 |
1438.13 |
82.28 |
| Operating Income (OI) |
1423.58 |
100.00 |
1028.81 |
100.00 |
1747.94 |
100.00 |
| OPBDIT |
157.40 |
11.06 |
-57.51 |
-5.59 |
294.14 |
16.83 |
| OPBDT |
82.31 |
5.78 |
-262.94 |
-25.56 |
108.09 |
6.18 |
| OPBT |
-55.11 |
-3.87 |
-369.04 |
-35.87 |
5.05 |
0.29 |
| Non-Operating Income |
4.52 |
0.32 |
5.11 |
0.50 |
1.92 |
0.11 |
| Extraordinary/Prior Period |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Tax |
0.40 |
0.03 |
0.00 |
0.00 |
28.54 |
1.63 |
| Profit after tax(PAT) |
-50.99 |
-3.58 |
-363.92 |
-35.37 |
-21.57 |
-1.23 |
| Cash Profit |
86.42 |
6.07 |
-257.83 |
-25.06 |
81.47 |
4.66 |
| Dividend-Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-06 |
|
31-Mar-05 |
|
31-Mar-04 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
2418.58 |
67.90 |
2340.98 |
68.16 |
2312.09 |
54.20 |
| Net Block |
1593.80 |
44.74 |
1611.02 |
46.91 |
1684.72 |
39.49 |
| Capital WIP |
31.91 |
0.90 |
1.98 |
0.06 |
0.80 |
0.02 |
| Investments |
225.21 |
6.32 |
226.21 |
6.59 |
254.62 |
5.97 |
| Inventory |
362.98 |
10.19 |
401.55 |
11.69 |
393.41 |
9.22 |
| Receivables |
496.07 |
13.93 |
413.95 |
12.05 |
690.75 |
16.19 |
| Other Current Assets |
852.08 |
23.92 |
779.72 |
22.70 |
1241.37 |
29.10 |
| Balance Sheet Total(BT) |
3562.04 |
100.00 |
3434.43 |
100.00 |
4265.67 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
268.47 |
7.54 |
255.13 |
7.43 |
214.32 |
5.02 |
| Reserves |
220.40 |
6.19 |
-27.06 |
-0.79 |
1309.25 |
30.69 |
| Total Debt |
2226.37 |
62.50 |
2317.63 |
67.48 |
1889.62 |
44.30 |
| Creditors and Acceptances |
577.54 |
16.21 |
527.34 |
15.35 |
536.20 |
12.57 |
| Other current liab/prov. |
269.26 |
7.56 |
361.39 |
10.52 |
316.27 |
7.41 |
| Balance Sheet Total(BT) |
3562.04 |
100.00 |
3434.43 |
100.00 |
4265.67 |
100.00 |
|
| As on |
31-Mar-06 |
31-Mar-05 |
31-Mar-04 |
| OPBIT/Prod.cap.empl.(%) |
0.81 |
-7.06 |
6.05 |
| PBIT/Cap. Employed (%) |
0.91 |
-6.23 |
5.66 |
| PAT/Networth (%) |
-10.43 |
-159.57 |
-1.42 |
| Tax/PBT (%) |
-0.79 |
0.00 |
409.71 |
| Total Debt/Networth (x) |
4.55 |
10.16 |
1.24 |
| Long Term Debt/Networth (x) |
1.59 |
7.67 |
0.78 |
| PBDIT/Finance Charges (x) |
2.16 |
-0.26 |
1.59 |
| Current Ratio (x) |
2.02 |
1.79 |
2.73 |
| RM Inventory (days consumption) |
143.47 |
159.39 |
110.42 |
| FG inventory (days cost of sales) |
9.09 |
29.43 |
8.72 |
| Receivables (days gross sales) |
133.85 |
137.31 |
166.54 |
| Creditors (days cost of sales) |
166.49 |
177.19 |
134.62 |
| Op. curr. assets (days OI) |
287.00 |
357.00 |
367.00 |
|
|
Financials